The chemical space, encompassing all possible small organic molecules, is vast, with only a tiny fraction explored. However, these explorations have greatly enhanced our understanding of biology and led to the development of many drugs. Biological systems have evolved to perform complex chemistry in aqueous environments, relying on enzymes and other proteins to control reactions. Despite the vast chemical space, biological systems use a small fraction of possible molecules, suggesting that 'biologically relevant chemical space' is a minute fraction of complete chemical space. Natural proteins are also a select group of molecules, with their properties linked to small molecules used in living systems and drugs. Understanding this link is crucial for using new methods to probe biological systems. Biological molecules are crowded within cells, affecting binding affinities and reaction rates. This crowding is important when interpreting in vitro data for in vivo processes. Biological systems are increasingly viewed as interconnected networks, not just isolated components. Techniques like X-ray crystallography, NMR, and electron microscopy have revolutionized our understanding of biological structures. Computational methods are also being developed to simulate molecular behavior within cells. Drug discovery faces challenges due to the vast chemical space and the need to find compounds that interact specifically with targets without causing adverse effects. Natural products and their derivatives are important in drug discovery, with many drugs being natural products or inspired by them. However, the number of new targets identified is small, and the number of druggable proteins is limited. The use of chemical tools to probe biological systems is growing, with techniques like chemical genetics and RNA interference becoming important in drug discovery. The future of drug discovery lies in leveraging large-scale screening data and computational methods to identify promising therapeutic compounds. Public databases and initiatives like the Molecular Libraries Screening Centers are helping to expand access to chemical information. Interdisciplinary collaborations are essential for advancing drug discovery and understanding the chemistry of life. The challenge remains to discover and understand the fraction of chemical space used by living systems and how much more could be used to influence them. Progress in this area will lead to more efficient strategies for drug discovery and a deeper understanding of how life began and evolved.The chemical space, encompassing all possible small organic molecules, is vast, with only a tiny fraction explored. However, these explorations have greatly enhanced our understanding of biology and led to the development of many drugs. Biological systems have evolved to perform complex chemistry in aqueous environments, relying on enzymes and other proteins to control reactions. Despite the vast chemical space, biological systems use a small fraction of possible molecules, suggesting that 'biologically relevant chemical space' is a minute fraction of complete chemical space. Natural proteins are also a select group of molecules, with their properties linked to small molecules used in living systems and drugs. Understanding this link is crucial for using new methods to probe biological systems. Biological molecules are crowded within cells, affecting binding affinities and reaction rates. This crowding is important when interpreting in vitro data for in vivo processes. Biological systems are increasingly viewed as interconnected networks, not just isolated components. Techniques like X-ray crystallography, NMR, and electron microscopy have revolutionized our understanding of biological structures. Computational methods are also being developed to simulate molecular behavior within cells. Drug discovery faces challenges due to the vast chemical space and the need to find compounds that interact specifically with targets without causing adverse effects. Natural products and their derivatives are important in drug discovery, with many drugs being natural products or inspired by them. However, the number of new targets identified is small, and the number of druggable proteins is limited. The use of chemical tools to probe biological systems is growing, with techniques like chemical genetics and RNA interference becoming important in drug discovery. The future of drug discovery lies in leveraging large-scale screening data and computational methods to identify promising therapeutic compounds. Public databases and initiatives like the Molecular Libraries Screening Centers are helping to expand access to chemical information. Interdisciplinary collaborations are essential for advancing drug discovery and understanding the chemistry of life. The challenge remains to discover and understand the fraction of chemical space used by living systems and how much more could be used to influence them. Progress in this area will lead to more efficient strategies for drug discovery and a deeper understanding of how life began and evolved.